In Vitro Activities of Garenoxacin (BMS-284756) against Streptococcus pneumoniae, Viridans Group Streptococci, and Enterococcus faecalis Compared to Those of Six Other Quinolones

The activity of garenoxacin, a new quinolone, was determined in comparison with other quinolones against different strains of S. pneumoniae, viridans group streptococci (VGS), and Enterococcus faecalis. Strains were quinolone-susceptible clinical isolates and quinolone-resistant strains with defined...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Grohs, Patrick, Houssaye, Serge, Aubert, Agnès, Gutmann, Laurent, Varon, Emmanuelle
Format: Artigo
Idioma:Inglês
Publicat: American Society for Microbiology 2003
Matèries:
Susceptibility
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC253772/
https://ncbi.nlm.nih.gov/pubmed/14576115
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.47.11.3542-3547.2003
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars